IL6 and COVID-19: Moreover, IL-6 levels were reduced by 55% in critical COVID-19 patients from the second wave compared to the first wave [41.3; IQR 27.2–51.2 versus 92.2; IQR 55.3–138.2] but this was not observed for severe COVID-19 patients (Table 3).